NCT06920043 A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH Status RECRUITING Phase PHASE2
NCT06911775 Eosinophil Subpopulations in Eosinophilic-associated Diseases Status NOT_YET_RECRUITING Phase N/A
NCT06897527 A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC) Status NOT_YET_RECRUITING Phase PHASE4
NCT06887933 A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE4
NCT06885034 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed Status RECRUITING Phase PHASE1/PHASE2
NCT06868667 Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06868654 China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06855160 A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age Status RECRUITING Phase PHASE3
NCT06847867 A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome Status RECRUITING Phase PHASE2
NCT06811155 Non-Interventional Study to Describe the Clinical Management in Asthmatic Patients (NICMA) Status COMPLETED Phase N/A
NCT06806137 A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age Status RECRUITING Phase PHASE3
NCT06796907 A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06790303 Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2 Status TERMINATED Phase PHASE2
NCT06763783 Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases Status ENROLLING_BY_INVITATION Phase PHASE4
NCT06757244 DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer Status RECRUITING Phase PHASE2
NCT06748053 A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06747845 Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy Status RECRUITING Phase PHASE2
NCT06740630 A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age Status RECRUITING Phase PHASE3
NCT06734234 A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease Status RECRUITING Phase PHASE1
NCT06727136 A Study to Characterize Single and Repeat Dose Pharmacokinetics of Tebipenem-Pivoxil-Hydrobromide (TBP-PI-HBr) and Its Major Metabolite (SPR1349) in Healthy Participants Status COMPLETED Phase PHASE1